by 
The global breast reconstruction market describes reconstruction procedures that are used to rebuild a breast’s shape and form after a mastectomy or lumpectomy surgery. These procedures make use of breast implants, the patient’s own tissue, or a combination of both to reconstruct the removed breast tissue.
Breast reconstruction procedures aim to restore symmetry, proportion and shape after breast cancer treatment. These procedures have proven psychological benefits for patients and have improved drastically over the years with advances in medical technologies and techniques. The use of more refined and natural-looking implants along with tissue flap techniques have made reconstruction a more viable and appealing option as compared to external prostheses. Owing to rising awareness and early detection, breast cancer treatment is increasingly moving towards conservative surgeries like lumpectomy rather than full mastectomy, further driving the need for partial and total breast reconstruction procedures.
The Global Breast Reconstruction Market is estimated to be valued at US$ 2.1 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. The breast reconstruction market leaders are focusing on advancing their tissue expander and implant portfolios with new profiles and textures.
Rising incidence of breast cancer worldwide is slated to drive the demand for breast reconstruction surgeries. According to the National Cancer Institute, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the US in 2022. Further, breast cancer reconstruction allows women to regain confidence and feeling of wholeness after battling cancer.
Key players are expanding globally to tap the potential growth opportunities in emerging markets. For instance, in 2020, Polytech announced plans to expand its footprint in Asia Pacific and Latin America over the next five years. The company also strengthened its strategic presence in key European markets through local sales offices and subsidiaries.
Market Key Trends
One of the major trends gaining traction in the breast reconstruction market is the increasing adoption of 3D printing or additive manufacturing technologies. 3D-printed breast implants offer benefits like personalized sizing, natural texture, weight and feel. For example, Anthropic offers AI-designed, 3D-printed soft-tissue breast implants that are designed to mimic natural breast structure. These implants are biocompatible, customizable and allow for a natural cosmetic appearance with minimal scarring. Rise in adoption of such advanced technologies is expected to positively impact the breast reconstruction market over the forecast period.
Porter’s Analysis
Threat of new entrants: Raising capital for facilities and equipment together with establishing a distribution network poses high costs for new entrants.
Bargaining power of buyers: Individual consumers have less bargaining power compared to large healthcare facilities.
Bargaining power of suppliers: There exist many suppliers for raw materials and implants, giving them less bargaining power.
Threat of new substitutes: While alternative breast reconstructive procedures exist, there is no close substitute for implants and tissue expansion procedures.
Competitive rivalry: Being a specialized segment, companies compete based on efficacy, convenience and after-sales services to gain higher market share.
Geographical Regions
North America accounts for the largest share in the breast reconstruction market in terms of value owing to favorable reimbursement policies and growing cancer rates in the US and Canada. The American Society of Plastic Surgeons (ASPS) had reported over 125,000 breast reconstruction procedures in the US for 2018.
Asia Pacific is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, growing medical tourism and increasing public awareness about breast cancer are driving the market in Asia Pacific countries like China, India and Japan.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
